4.5 Article

Impact of Systemic Corticosteroids on Healthcare Utilization in Patients With Sarcoidosis

Journal

AMERICAN JOURNAL OF THE MEDICAL SCIENCES
Volume 341, Issue 3, Pages 196-201

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1097/MAJ.0b013e3181fe3eb2

Keywords

Corticosteroids; Sarcoidosis; Healthcare utilization; Hospitalizations; Prednisone

Ask authors/readers for more resources

Introduction: Practical complications of chronic systemic corticosteroid (SC) use in patients with sarcoidosis are poorly characterized. The objective of this study was to determine the impact of SC use in patients with sarcoidosis on unscheduled sarcoidosis-attributed and non-sarcoidosis-attributed healthcare utilization (SHCU and NSHCU, respectively). Methods: Retrospective analysis of patient-reported HCU between clinic visits at a university hospital sarcoidosis outpatient clinic. Results: A total of 441 included patients had a mean (standard deviation) of 2.4 (1.2) organs involved, were followed up for a mean of 2.9 (2.4) years and received a median cumulative dose of 2680 mg of prednisone. Patients in the higher 50th percentile of cumulated SC reported a higher unadjusted mean annual SHCU (0.33 versus 0.22, P < 0.0001 by Wilcoxon rank-sum test) but a similar mean annual NSHCU (0.83 versus 1.00, P = 0.88). After adjustment for age, race and sex, persons in the higher 50th percentile of corticosteroid exposure had a similar odds of overall NSHCU (adjusted odds ratio = 1.03, 95% CI = 0.74-1.44) but a 2.2 (95% CI = 1.5-3.3) odds of greater nonsarcoidosis attributable emergency department visits. In separate analysis of the reasons for NSHCU, persons with greater SC use had a 1.74 (95% CI = 1.16-2.62) odds of more infectious disease-related complaints and a trend toward more visits for cardiovascular problems (OR = 1.49, 95% CI = 0.96-2.32). Conclusions: Greater SC use is associated with small but significant increase in HCU related to infection and increased unscheduled emergency department visits for complaints not directly attributable to sarcoidosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Critical Care Medicine

Clinical Course of Sarcoidosis in World Trade Center-Exposed Firefighters

Kerry M. Hena, Jennifer Yip, Nadia Jaber, David Goldfarb, Kelly Fullam, Krystal Cleven, William Moir, Rachel Zeig-Owens, Mayris P. Webber, Daniel M. Spevack, Marc A. Judson, Lisa Maier, Andrew Krumerman, Anthony Aizer, Simon D. Spivack, Jessica Berman, Thomas K. Aldrich, David J. Prezant

CHEST (2018)

Review Critical Care Medicine

Drug-Induced Sarcoidosis-Like Reactions

Amit Chopra, Amit Nautiyal, Alexander Kalkanis, Marc A. Judson

CHEST (2018)

Article Cardiac & Cardiovascular Systems

The development of sarcoidosis in patients receiving daclizumab: A case series from multiple clinical trials

Marc A. Judson, Brett M. Elicker, Thomas V. Colby, Sooyeon Kwon, Elizabeth de Windt, Spyros Chalkias, Claudia Prada, Karen Smirnakis, Priya Singhal

RESPIRATORY MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis

Marc A. Judson, Sara Preston, Kurt Hu, Robert Zhang, Stephanie Jou, Aakash Modi, Indrawattie Sukhu, Furqan Ilyas, Gavril Rosoklija, Recai Yucel

RESPIRATORY MEDICINE (2019)

Editorial Material Cardiac & Cardiovascular Systems

Screening sarcoidosis patients for cardiac sarcoidosis: What the data really show

Marc A. Judson

RESPIRATORY MEDICINE (2019)

Editorial Material Medicine, General & Internal

The epidemic of drug-induced sarcoidosis-like reactions: a side effect that we can live with

M. A. Judson

JOURNAL OF INTERNAL MEDICINE (2020)

Review Critical Care Medicine

Management of Advanced Pulmonary Sarcoidosis

Rohit Gupta, Marc A. Judson, Robert P. Baughman

Summary: Advanced sarcoidosis is a form of sarcoidosis that poses a significant risk of organ function loss or death, with the lung being the most commonly affected organ. It can lead to complications such as pulmonary fibrosis and bronchiectasis. Although it affects a small proportion of patients, it is the leading cause of poor outcomes.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Health Care Sciences & Services

Quality of Life and Physical Activity in 629 Individuals With Sarcoidosis: Prospective, Cross-sectional Study Using Smartphones (Sarcoidosis App)

Brian Chu, Daniel M. O'Connor, Marilyn Wan, Ian Barnett, Haochang Shou, Marc Judson, Misha Rosenbach

Summary: The study utilized a smartphone app to investigate the impact of sarcoidosis on quality of life, physical activity, and medication usage. Findings showed that a significant number of participants experienced missed school or work days and financial impacts due to the disease.

JMIR MHEALTH AND UHEALTH (2022)

Review Medicine, General & Internal

The Management of Sarcoidosis in the 2020s by the Primary Care Physician

Marc A. Judson

Summary: Sarcoidosis is a global idiopathic granulomatous disease that can affect any organ. Primary care physicians play a crucial role in assessing and managing sarcoidosis patients, as the symptoms are not specific. This article provides guidelines for the evaluation, treatment, and monitoring of sarcoidosis patients by primary care physicians.

AMERICAN JOURNAL OF MEDICINE (2023)

Article Critical Care Medicine

Pressure-Dependent Pneumothorax and Air Leak Physiology and Clinical Implications

Amit Chopra, Peter Doelken, Kurt Hu, John T. Huggins, Marc A. Judson

Summary: Pressure-dependent pneumothorax is a common occurrence after pleural drainage in patients with visceral pleural restriction, partial lung resection, or lobar atelectasis. It is important to recognize this type of pneumothorax as it does not require further intervention.

CHEST (2023)

Editorial Material Medicine, General & Internal

Deconstructing Multiorgan Sarcoidosis

Marc A. Judson

JOURNAL OF CLINICAL MEDICINE (2023)

Editorial Material Critical Care Medicine

A 74-Year-Old Man With Dyspnea

Ibrahim Khatim, Marc A. Judson, Artcar Htoo, Amit Chopra

CHEST (2023)

Article Respiratory System

The Relationship Between Serum Angiotensin Converting Enzyme Level and the Decision to Escalate Treatment of Sarcoidosis

Boris Shkolnik, Rou Sore, Muhammad Salick, Gowthami Kobbari, Sana Ghalib, Anoosh S. Parimi, Kenneth M. Fish, Robert Deluca, Recai Yucel, Marc A. Judson

Summary: This study retrospectively analyzed a cohort of patients with sarcoidosis and found that sACE is not reliable enough to be used as the sole determinant of treatment escalation.
Review Medicine, General & Internal

The Symptoms of Pulmonary Sarcoidosis

Marc A. Judson

Summary: This manuscript provides a comprehensive review of the etiology, measurement, and treatment of common pulmonary symptoms associated with sarcoidosis. It emphasizes the importance of thorough assessment of symptoms, as they serve as useful tools in diagnosis and treatment.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Respiratory System

An Artificial Intelligence Platform for the Radiologic Diagnosis of Pulmonary Sarcoidosis: An Initial Pilot Study of Chest Computed Tomography Analysis to Distinguish Pulmonary Sarcoidosis from a Negative Lung Cancer Screening Scan

Marc A. Judson, Jianwei Qiu, Camille L. Dumas, Jun Yang, Brion Sarachan, Jhimli Mitra

Summary: The AI/DL-based method using chest CT scan analysis shows promise in reliably distinguishing pulmonary sarcoidosis from negative lung cancer screening chest CT scans.
No Data Available